EDN1 and chronic kidney disease: Endothelin-1 (ET-1) activates endothelin A (ETA) receptors across multiple kidney cell types, and this can lead to vasoconstriction, podocyte injury, inflammation, and fibrosis, which leads to the progression of CKD [100,111], which in turn contributes to IgAN pathogenesis.